Our cohort consisted of 82,717 patients newly diagnosed with COPD. During a total follow-up of 274,025 patient-years, there were 6,234 CVEs, for a rate of 2.2 CVEs per 100 patient-years. A plurality ...
Review the side-effects of Albuterol and Ipratropium as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In ...
Learn everything you need to know about Ipratropium Bromide-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Lupin is releasing Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, which are the generic of Boehringer Ingelheim’s Atrovent Nasal Spray, 0.03% and 0.06%. Ipratropium Bromide Nasal ...
A 55-year-old man with hypertension, hyperlipidemia, and chronic obstructive pulmonary disease (COPD) secondary to a 45 pack-year history presents with cough, wheezing, and dyspnea at rest. He reports ...
(HealthDay News) — There are no significant clinical differences between the use of a breath-actuated nebulizer (BAN) and a handheld nebulizer (HHN) for the treatment of wheezing or dyspnea among ...
Global pharma major Lupin Limited (Lupin) announced the launch of ipratropium bromide nasal solution (nasal spray), 0.03% and 0.06%, in the United States. Ipratropium bromide nasal solution (nasal ...
We used national Veteran's Health Administration health-care databases for this analysis, including inpatient and outpatient data, pharmacy data, and vital status information. The cohort in this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results